CervoMed Inc. - Common Stock, $0.001 par value (CRVO) Institutional Ownership

13F Institutional Holders and Ownership History from Q3 2023 to Q4 2025

Type / Class
Equity / Common Stock, $0.001 par value
Symbol
CRVO on Nasdaq
Shares outstanding
10,373,101
Price per share
$7.90
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares
2,131,766
Total reported value
$17,245,377
% of total 13F portfolios
0%
Share change
-14,640
Value change
+$167,311
Number of holders
43
Price from insider filings
$7.90
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of CervoMed Inc. - Common Stock, $0.001 par value (CRVO) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
RA CAPITAL MANAGEMENT, L.P. 9.9% 0% $9,571,053 +$1,033,346 1,026,937 +12% RA Capital Management, L.P. 30 Jun 2025
AWM Investment Company, Inc. 9.9% +104% $7,337,200 +$3,893,298 863,200 +113% AWM Investment Company, Inc. 31 Mar 2025

As of 30 Sep 2025, 43 institutional investors reported holding 2,131,766 shares of CervoMed Inc. - Common Stock, $0.001 par value (CRVO). This represents 21% of the company’s total 10,373,101 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of CervoMed Inc. - Common Stock, $0.001 par value (CRVO) together control 21% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
AWM Investment Company, Inc. 8.3% 863,200 0% 0.65% $6,983,288
MORGAN STANLEY 4% 414,037 +10% 0% $3,349,559
VANGUARD GROUP INC 3.3% 343,463 +1% 0% $2,778,616
MILLENNIUM MANAGEMENT LLC 0.69% 71,509 -6% 0% $578,508
GEODE CAPITAL MANAGEMENT, LLC 0.62% 64,467 +19% 0% $521,683
BlackRock, Inc. 0.47% 48,832 -53% 0% $395,051
CITADEL ADVISORS LLC 0.29% 30,510 0% $246,826
CITIZENS FINANCIAL GROUP INC/RI 0.29% 30,477 +14% 0% $246,559
Perigon Wealth Management, LLC 0.28% 28,731 +66% 0% $232,434
Cetera Investment Advisers 0.26% 27,440 0% $221,990
Savvy Advisors, Inc. 0.25% 25,922 0.01% $209,709
NORTHERN TRUST CORP 0.22% 22,554 -11% 0% $182,461
STATE STREET CORP 0.18% 18,427 -2.6% 0% $149,074
Hilton Capital Management, LLC 0.17% 17,315 0.01% $140,078
TWO SIGMA INVESTMENTS, LP 0.16% 17,108 0% $138,404
THOMPSON DAVIS & CO., INC. 0.16% 16,850 +21% 0.08% $136,317
Russell Investments Group, Ltd. 0.16% 16,610 -1.2% 0% $134,375
READYSTATE ASSET MANAGEMENT LP 0.14% 14,534 0.01% $117,580
Cornerstone Wealth Management, LLC 0.13% 13,470 -25% 0.01% $108,975
FMR LLC 0.11% 11,537 -4.2% 0% $93,334
GSA CAPITAL PARTNERS LLP 0.11% 11,307 0.01% $91,000
HighTower Advisors, LLC 0.11% 11,244 0% 0% $90,964
UBS Group AG 0.03% 3,376 -40% 0% $27,312
JPMORGAN CHASE & CO 0.02% 1,975 0% $15,978
PRINCIPAL SECURITIES, INC. 0.02% 1,665 +909% 0% $13,470

Institutional Holders of CervoMed Inc. - Common Stock, $0.001 par value (CRVO) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 54,501 $430,558 +$67,698 $7.90 5
2025 Q3 2,131,766 $17,245,377 +$167,311 $8.09 43
2025 Q2 2,173,154 $13,657,601 -$929,088 $6.28 42
2025 Q1 2,283,165 $20,892,442 +$8,828,451 $9.15 45
2024 Q4 1,485,110 $3,460,366 -$33,750,757 $2.34 42
2024 Q3 3,505,695 $51,186,077 +$594,724 $14.60 48
2024 Q2 3,446,957 $59,012,253 +$15,847,464 $17.12 38
2024 Q1 2,514,408 $58,586,040 +$50,991,141 $23.30 20
2023 Q4 326,045 $2,477,695 -$43,377 $7.63 11
2023 Q3 363,667 $1,681,783 +$1,681,785 $4.62 12